ArticleLeukemia research2022
De Novo myelodysplastic syndromes in patients 20-50 years old are enriched for adverse risk features.
Zachary D Epstein-Peterson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it